The Beckley Foundation

Call Directions Website Contact the organisation

The Beckley Foundation Find us on Twitter or Instagram

We carry out scientific research into psychoactive drugs and consciousness, and promote evidence-based, health-oriented drug policy reform, led by Amanda Feilding.

This weekend, Amanda’s artwork will feature among a stellar group of artists for a multi-sensory  experience from Double...
14/10/2026

This weekend, Amanda’s artwork will feature among a stellar group of artists for a multi-sensory experience from DoubleMoon at Town Hall by Bottaccio Town Hall by Bottaccio

The Salon exhibition traces a lineage of artists who have used light to alter the mind, and will run from the 17th October to 20th December.

On the 17-18 October, the Vision Hall installation will feature four 40-minute conversations with neuroscientists, philosophers, artists, and researchers.

🌙🌙 More details DoubleMoon

A new study of ayahuasca retreat participants found that the people best equipped to cope with adversity tended to have ...
05/10/2026

A new study of ayahuasca retreat participants found that the people best equipped to cope with adversity tended to have the most intense difficult experiences during their ceremonies. Researchers followed 233 people attending retreats in Costa Rica and Peru, measuring their psychological resilience beforehand, the difficulty of their experience immediately afterwards, and their sense of meaning in life a month later.

Resilience here means the capacity to adapt to hardship and recover from it. The researchers had expected more resilient people to have an easier time, since resilience usually buffers against stress, yet they found the reverse: higher resilience predicted more intense experiences of fear, grief and emotional distress. The authors suggest this may be because resilient people feel more able to stay with difficult emotional material as the mind’s usual defences loosen. A second, more tentative finding that the authors stress needs further testing, was that among those who had intense experiences, the more resilient were more likely to emerge searching for meaning in their lives a month on.

This was an observational study of people who chose to attend an ayahuasca retreat, so it can’t establish cause, with a largely white, North American and well educated population. Even so, it offers a more nuanced picture around challenging psychedelic experiences.

📑 Baseline Resilience as a Predictor of Ayahuasca Acute Effects and Moderator of the Relationship between Acute Effects and Psychospiritual Outcomes – Xin et al., 2026

https://journals.sagepub.com/doi/10.1177/28314425261448756

A new study drawing on two large UK birth cohorts, covering more than 21,000 people, found that those who had used psilo...
23/09/2026

A new study drawing on two large UK birth cohorts, covering more than 21,000 people, found that those who had used psilocybin or L*D at least once in their lifetime were more likely to hold pro-environmental attitudes and to follow a vegetarian diet. Past psilocybin users in particular reported a broadly healthier eating pattern, including more salads and raw vegetables. Analysis pointed to people’s environmental views as what linked their psychedelic use to their diet.

A retrospective study like this one can only show possible associations rather than causes, but the population-level view makes it interesting in a field where questions are usually studied through small samples. So while participants were reporting on their own past use and habits, and people already inclined towards nature and vegetarianism may be more drawn to psychedelics in the first place, the findings suggest that shifts in how people relate to the natural world may be part of why their habits change.

📑 Lifetime classic psychedelics use is associated with positive environmental attitudes and adopting a vegetarian diet – Teixeira et al., 2026

https://www.nature.com/articles/s41598-026-71275-x_reference.pdf

🌵🧠✨ A new study in rats has produced the first comprehensive brain imaging profile of mescaline, one of the oldest known...
15/09/2026

🌵🧠✨ A new study in rats has produced the first comprehensive brain imaging profile of mescaline, one of the oldest known psychedelics. Mescaline is the active compound in pe**te and San Pedro cacti and has been used ceremonially across the Americas for thousands of years, but its restricted legal status has meant almost no imaging work until now.

Researchers scanned the brains of awake rats given mescaline and found a pattern that sets it apart from psilocybin and L*D: activity in the cerebellum, a region traditionally associated with movement and coordination, was strongly suppressed, while at the same time it formed a surge of new connections to areas including the hippocampus, thalamus and sensory cortex. The researchers interpret this as the cerebellum losing its normal role as a filter that sorts expected sensory information from the unexpected, so that instead of screening incoming signals it floods the rest of the brain with unfiltered ones, which they suggest could relate to the altered perception psychedelics produce.

This was a study in rats given a single dose, so it can show which brain circuits mescaline acts on but not what the animals actually experienced. The authors are careful to note that patterns seen in rodents may not carry over to humans, and that the imaging method has limits of its own. What it offers is the fullest scientific imaging of mescaline to date, and a sign that different psychedelics may work through distinct pathways rather than one shared mechanism.

📑 Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats – Cavallaro et al., 2026

https://link.springer.com/article/10.1007/s12264-026-01632-3

A new Beckley Retreats article examines the research around experiential therapy and lasting change.“Emerging research s...
02/09/2026

A new Beckley Retreats article examines the research around experiential therapy and lasting change.

“Emerging research suggests that psychedelic-therapies create a “critical window” of psychological flexibility following treatment whereby neurons can more easily break old connections and form new ones, helping to foster long-term behavioural change.

By pairing emotional insight gained through psychotherapy with the practice of new habits, behaviours, regulation of the nervous system and emotional responses, individuals can work on developing long-term, meaningful change.”

https://www.beckleyretreats.com/blog/why-cant-i-change-my-patterns-even-with-therapy

In a fascinating new paper, researchers challenge a common description of the psychedelic state as one of “disorder” in ...
26/08/2026

In a fascinating new paper, researchers challenge a common description of the psychedelic state as one of “disorder” in the brain.

Sixty-two people with no previous psychedelic experience underwent fMRI and EEG scans before and after taking psilocybin, while resting, meditating, listening to music and watching a film.

Using machine learning to track how brain activity unfolded moment to moment, the researchers found that what looks like randomness in conventional averaged measures is in fact organised: under psilocybin, brain activity reorganised into structured patterns closely shaped by what the person was doing and experiencing at the time. Networks that normally keep internal thought and external sensory input separate began to merge, and this merging was strongest in people who reported feeling continuous with their surroundings rather than separate from them, a state the authors call “embeddedness.”

The stronger that experience, the greater both the reorganisation in the brain and the shifts in the person’s outlook the next day, which the researchers suggest may help explain how the psychedelic experience itself, and the setting it takes place in, translates into lasting change. This was a healthy sample given a single dose with no blinded placebo, so it does more to illuminate mechanism rather than treatment, but it offers a richer picture of how the psychedelic state is organised in the brain.

📑 Psychedelics align brain activity with context – Stoliker et al., 2026

DOI: 10.1038/s41586-026-10910-z

https://www.nature.com/articles/s41586-026-10910-z

A new article from  Beckley Retreats explores how psilocybin may specifically help the bereaved deepen their emotional p...
20/08/2026

A new article from Beckley Retreats explores how psilocybin may specifically help the bereaved deepen their emotional processing and reconnect with what makes life feel meaningful. While research on psilocybin for grief is still in the early stages, adjacent studies centered on issues like depression and end-of-life anxiety or existential distress offer a valuable foundation for exploration.

Studies Involving Existential Distress or End-of-life Anxiety:

Two widely cited clinical trials published in 2016 provide insight into psilocybin’s potential use for grief. These studies found that psilocybin-assisted therapy, combined with psychological support, significantly reduced anxiety and depression in patients with life-threatening cancer.

📄Griffiths, et al., 2016 reported that a single high-dose psilocybin session produced substantial and sustained reductions in depression and anxiety in 80% of participants.

📄Ross, et al., 2016 similarly reported rapid and lasting improvements in emotional well-being for participants with existential distress.

Importantly, participants described changes in their relationship to their mortality. Many said their experiences centered around forgiveness, connection, love, or acceptance of death. Although these studies did not focus specifically on grief, they suggest that psilocybin may help individuals navigate emotionally and existentially difficult experiences.

https://www.beckleyretreats.com/blog/psilocybin-for-grief-and-loss

Tomorrow, ticket prices for the World Ayahuasca Forum will increase from €395 to €495. If you’re planning to join us in ...
14/08/2026

Tomorrow, ticket prices for the World Ayahuasca Forum will increase from €395 to €495. If you’re planning to join us in Girona this September, today is the last day to secure your Advance Ticket at the current rate. Join us for three days of dialogue, connection, and collective reflection on the future of ayahuasca and Indigenous medicines.

September 11–13, 2026 · Girona, Spain

https://www.ayahuasca2026.com/tickets/

A new psychedelic survey from UCL is seeking to understand how psychedelics and related drugs affect different people ac...
14/08/2026

A new psychedelic survey from UCL is seeking to understand how psychedelics and related drugs affect different people across the lifespan.

See details and the link to contribute your experience to psychedelic research below:

https://qualtrics.ucl.ac.uk/jfe/form/SV_a44pPupnpjzL5ie

A new ethnographic study sheds light on the changes in the usage, customs and knowledge of Psilocybe mushrooms in a Zapo...
14/08/2026

A new ethnographic study sheds light on the changes in the usage, customs and knowledge of Psilocybe mushrooms in a Zapotec community in Oaxaca, Mexico.

🖇️ Full paper on our Psychedelic Links in our bio

Current use of holy mushrooms of the genus Psilocybe in a Zapotec community in Oaxaca, Mexico. Haro-Luna MX, Ruan-Soto F, Ramírez-Cruz V, Amaya-Pérez J, Guzmán-Dávalos L (2025)

📷✨ Photo Credit: Alan Rockefeller

Address

Beckley Park
Oxford
OX39SY

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+441865351019

Alerts

Be the first to know and let us send you an email when The Beckley Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organisation

Send a message to The Beckley Foundation:

Shortcuts

Share